Back to the main directory
Press Release
- Danske Bank A/S, transactions by persons discharging managerial responsibilities by GlobeNewsWire
- EQS-News: Heidelberg Pharma veranstaltet F&E-Webinar im Anschluss an Präsentation neuer Daten auf der AACR-Tagung by EQS Group AG
- Innate Pharma publie son Document D’enregistrement Universel 2023 et son Rapport Annuel 2023 sur « Form 20-F » by BusinessWire
- Petrofac Limited: Director/PDMR shareholding by EQS Group AG
- Accelerating forward Thailand’s cement roadmap, Dr. Chana Poomee, TCMA Chairman, is set to strengthen tie with global green funds boosting Thai industry competitiveness and effort to achieve the Net Zero 2050 by EQS Group AG
- EQS-News: APONTIS PHARMA schließt fünfjährige Distributions- und Vermarktungsvereinbarung für zwei Asthma-Arzneimittel mit Novartis und erhöht Prognose by EQS Group AG
- AI-Media revolutioniert Untertitelung für DAZN mit KI-gestütztem LEXI Tool Kit by GlobeNewsWire
- AI-Media révolutionne le sous-titrage pour la plateforme DAZN avec le kit d’outils LEXI alimenté par l’IA by GlobeNewsWire
- AI-Media Merevolusionerkan Pemberian Teks untuk DAZN dengan Tool Kit LEXI yang Didukung AI by GlobeNewsWire
- AI-Media, AI 기반의 LEXI Tool Kit 통해 미디어기업 DAZN의 캡션 서비스에 혁신을 가져오다 by GlobeNewsWire
- A AI-Media Revoluciona Legendagem da DAZN com o LEXI Tool Kit com Base em IA by GlobeNewsWire
- AI-Media 革新为 DAZN 提供 AI 驱动的 LEXI Tool Kit 字幕服务 by GlobeNewsWire
- Himax to Showcase tinyML-Powered Versatile Ultralow Power WiseEye™ AI at embedded world Exhibition&Conference 2024 by GlobeNewsWire
- Resolutions of Martela Corporation Annual General Meeting by GlobeNewsWire
- TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution by EQS Group AG
- Tikehau Capital : Déclaration des transactions sur actions propres réalisées du 2 avril 2024 au 4 avril 2024 by BusinessWire
- Pharma Equity Group’s subsidiary, Reponex Pharmaceuticals A/S, reports highly positive final results from the phase-2 clinical trial of the company’s patented drug candidate RNX-051. by GlobeNewsWire
- EQS-News: The Platform Group AG: GMV, sales and earnings above forecast, positive outlook for 2024 confirmed, medium-term planning for 2025 by EQS Group AG
- Swiss Properties Invest A/S: Publication of the Company's Annual Report 2023 by GlobeNewsWire
- Notice to Annual General Meeting in Swiss Properties Invest A/S by GlobeNewsWire
- Festi hf.: Updated Financial Calendar 2024/25 by GlobeNewsWire
- HighCo: SHAREHOLDING AS 03/31/2024 by GlobeNewsWire
- Range Announces Conference Call to Discuss First Quarter 2024 Financial Results by GlobeNewsWire
- Teladoc Health Board of Directors Announces Leadership Transition by GlobeNewsWire
- HUB Cyber Security Secures $8 Million in Financing to Accelerate Growth and Strengthen Financial Position by GlobeNewsWire